Chronic Myeloid Leukemia Treatments

Работ: 32

1. THE SIGNIFICANCE OF DRIVER GENE MUTATIONS JAK2, CALR, AND MPL IN CHRONIC MYELOPROLIFERATIVE DISEASES

   Beknur Bobir ugli Giyosov, Kodirjon Tukhtaboevich Boboev, Feruz Asatullaevich Daminov

   СтатьяMyeloproliferative Neoplasms: Diagnosis and TreatmentZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.000959

2. Level and Serum Metabolism of Homocysteine in Chronic Myeloid Leukemia Patients: A Literature Review

   K. S. Samarina, Yuliana Yurevna Assesorova, I. V. Berger

   СтатьяChronic Myeloid Leukemia TreatmentsClinical oncohematology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.009963

3. Durable Disease Control in Disseminated Primary Splenic Leiomyosarcoma Treated With Sequential Gemcitabine–Docetaxel and Pazopanib Therapy: A Case Report

   Saida Kurbanova, Biloliddin Sharobiddinov, Oqila Abdusattorova +1

   СтатьяGastrointestinal Tumor Research and TreatmentCureus2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.010599

4. Possibilities of Cytogenetic Studies in Acute Myeloid Leukemia (Literature Review)

   Assessorova Yuliana Yurevna, Sadikova Shirin Erimmatovna, Madatov Kurbonboy Aminboevich

   СтатьяAcute Myeloid Leukemia ResearchInternational Journal of Medical Science and Public Health Research2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.014972

5. Method Development And Validation For Estimation Of Related Substances In Selpercatinib Bulk Dosage Form By Rp-Hplc Technique

   Mr. Suraj P. Rajurkar, Mr. Salman Ahmad Khan, Mr. Shivprasad Sanjay Dhage +5

   СтатьяChronic Myeloid Leukemia TreatmentsInternational Journal of Drug Delivery Technology2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.018569

6. PHARMACOLOGICAL PROPERTIES OF TYROSINE KINASE INHIBITORS: CURRENT PERSPECTIVES

   Kamola Anvarjon kizi Almirzayeva

   СтатьяChronic Myeloid Leukemia TreatmentsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.020463

7. PHARMACOLOGICAL PROPERTIES OF TYROSINE KINASE INHIBITORS: CURRENT PERSPECTIVES

   Kamola Anvarjon kizi Almirzayeva

   СтатьяChronic Myeloid Leukemia TreatmentsZenodo (CERN European Organization for Nuclear Research)2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.020637